Malignant pleural mesothelioma (MPM) is a rare and fatal disease of the pleural lining. Up to
80% of the MPM cases are linked to asbestos exposure. Even though its use has been …

Background The role of immunotherapy in cancer is now well-established, and therapeutic
options such as checkpoint inhibitors are increasingly being approved in many cancers such …

The immune system plays a central role in the onset and progression of cancer. A better
understanding of transcriptional changes in immune cell-related genes associated with …

Objectives To assess key elements of the design for Meso-ORIGINS (Mesothelioma
Observational study of RIsk prediction and Generation of paired benign-meso tissue …

Background Malignant serous effusion (MSE) denotes a manifestation of metastatic disease
with typical high concentrations of both cancer and immune cells, making them an ideal …

Simple Summary FGFR2-ER-PR crosstalk leads to hormone-independent progression of
breast cancer. In vitro, FGFR2 stimulates PR transcriptional activity and mediates resistance …

Malignant pleural effusion (MPE) is a common complication of lung adenocarcinoma
(LADC) which is associated with a dismal prognosis. We investigated the prognostic role of …

Spread of malignancies to serous cavities represents advanced stage disease that
necessitates systemic treatment. Immunochemistry (IC) is an indispensable tool to ascertain …

Pleural Mesothelioma (PM) is an incurable disease with a poor life expectancy. It is most
commonly associated with asbestos exposure and the latency period from exposure to PM …

Malignant pleural effusion (MPE) is a serious complication occurring when cancer cells are
found in the pleural cavity surrounding the lung. MPE is typically associated with highly …